loadpatents
name:-0.32292103767395
name:-0.037522077560425
name:-0.0064198970794678
NOTTE; Gregory Patent Filings

NOTTE; Gregory

Patent Applications and Registrations

Patent applications and USPTO patent grants for NOTTE; Gregory.The latest application filed is for "sulfinylaminobenzamide and sulfonylaminobenzamide derivatives".

Company Profile
5.43.42
  • NOTTE; Gregory - Redwood City CA
  • Notte; Gregory - San Mateo CA
  • Notte; Gregory - Foster City CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Sulfinylaminobenzamide And Sulfonylaminobenzamide Derivatives
App 20220055985 - FARAND; Julie ;   et al.
2022-02-24
Pd-1/pd-l1 Inhibitors
App 20210323922 - Aktoudianakis; Evangelos ;   et al.
2021-10-21
Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives
Grant 11,136,290 - Farand , et al. October 5, 2
2021-10-05
Apoptosis signal-regulating kinase inhibitors
Grant RE48,711 - Corkey , et al. August 31, 2
2021-08-31
Triazole Carbamate Pyridyl Sulfonamides As Lpa Receptor Antagonists And Uses Thereof
App 20210171500 - Bestvater; Brian P. ;   et al.
2021-06-10
Solid forms of an ASK1 inhibitor
Grant 10,946,004 - Andres , et al. March 16, 2
2021-03-16
Apoptosis signal-regulating kinase inhibitors
Grant RE48,150 - Corkey , et al. A
2020-08-11
Solid Forms Of An Ask1 Inhibitor
App 20200061042 - Andres; Mark ;   et al.
2020-02-27
Apoptosis signal-regulating kinase inhibitor
Grant 10,508,100 - Notte Dec
2019-12-17
Sulfinylaminobenzamide And Sulfonylaminobenzamide Derivatives
App 20190359565 - Farand; Julie ;   et al.
2019-11-28
Apoptosis Signal-regulating Kinase Inhibitor
App 20190248762 - Notte; Gregory
2019-08-15
Apoptosis signal-regulating kinase inhibitors
Grant 10,307,427 - Notte
2019-06-04
Apoptosis Signal-regulating Kinase Inhibitors
App 20180303844 - Notte; Gregory
2018-10-25
Pd-1/pd-l1 Inhibitors
App 20180305315 - Aktoudianakis; Evangelos ;   et al.
2018-10-25
Solid Forms Of An Ask1 Inhibitor
App 20180243281 - Andres; Mark ;   et al.
2018-08-30
Syk inhibitors
Grant 10,005,774 - Blomgren , et al. June 26, 2
2018-06-26
Apoptosis signal-regulating kinase inhibitors
Grant 9,943,521 - Notte April 17, 2
2018-04-17
Apoptosis Signal-regulating Kinase Inhibitor
App 20180099950 - NOTTE; GREGORY
2018-04-12
Solid forms of an ASK1 inhibitor
Grant 9,907,790 - Notte March 6, 2
2018-03-06
Apoptosis signal-regulating kinase inhibitors
Grant 9,908,875 - Notte March 6, 2
2018-03-06
Apoptosis signal-regulating kinase inhibitor
Grant 9,873,682 - Notte January 23, 2
2018-01-23
Apoptosis signal-regulating kinase inhibitor
Grant 9,750,730 - Notte September 5, 2
2017-09-05
Processes For Preparing Ask1 Inhibitors
App 20170233350 - Brown; Brandon Heath ;   et al.
2017-08-17
Apoptosis Signal-regulating Kinase Inhibitor
App 20170217933 - Notte; Gregory
2017-08-03
Solid Forms Of An Ask1 Inhibitor
App 20170209423 - Notte; Gregory
2017-07-27
Apoptosis Signal-regulating Kinase Inhibitors
App 20170196844 - GRAUPE; MICHAEL ;   et al.
2017-07-13
Apoptosis Signal-regulating Kinase Inhibitors
App 20170173031 - Notte; Gregory
2017-06-22
Fused heterocyclic compounds as ion channel modulators
Grant 9,682,998 - Corkey , et al. June 20, 2
2017-06-20
Solid forms of an ASK1 inhibitor
Grant 9,643,956 - Andres , et al. May 9, 2
2017-05-09
Apoptosis signal-regulating kinase inhibitors
Grant 9,586,932 - Graupe , et al. March 7, 2
2017-03-07
Processes for preparing ASK1 inhibitors
Grant 9,586,933 - Notte March 7, 2
2017-03-07
Syk Inhibitors
App 20160368918 - Blomgren; Peter ;   et al.
2016-12-22
Fused Heterocyclic Compounds As Ion Channel Modulators
App 20160362421 - Corkey; Britton Kenneth ;   et al.
2016-12-15
Apoptosis Signal-regulating Kinase Inhibitors
App 20160318922 - Notte; Gregory
2016-11-03
Apoptosis Signal-regulating Kinase Inhibitor
App 20160235728 - Notte; Gregory
2016-08-18
Fused heterocyclic compounds as ion channel modulators
Grant 9,403,782 - Corkey , et al. August 2, 2
2016-08-02
Substituted pyrrolidines as SYK inhibitors
Grant 9,376,441 - Currie , et al. June 28, 2
2016-06-28
Fused heterocyclic compounds as ion channel modulators
Grant 9,371,329 - Corkey , et al. June 21, 2
2016-06-21
Apoptosis Signal-regulating Kinase Inhibitors
App 20160130251 - Graupe; Michael ;   et al.
2016-05-12
Apoptosis signal-regulating kinase inhibitor
Grant 9,333,197 - Notte May 10, 2
2016-05-10
Apoptosis signal-regulating kinase inhibitor
Grant 9,254,284 - Notte February 9, 2
2016-02-09
Fused Heterocyclic Compounds As Ion Channel Modulators
App 20150329558 - Corkey; Britton Kenneth ;   et al.
2015-11-19
Apoptosis signal-regulating kinase inhibitors
Grant 9,169,243 - Notte October 27, 2
2015-10-27
Apoptosis Signal-regulating Kinase Inhibitors
App 20150246910 - Notte; Gregory
2015-09-03
Fused heterocyclic compounds as ion channel modulators
Grant 9,115,096 - Corkey , et al. August 25, 2
2015-08-25
Fused heterocyclic compounds as ion channel modulators
Grant 9,079,901 - Kobayashi , et al. July 14, 2
2015-07-14
Apoptosis signal-regulating kinase inhibitors
Grant 9,067,933 - Corkey , et al. June 30, 2
2015-06-30
Apoptosis Signal-regulating Kinase Inhibitors
App 20150175597 - Notte; Gregory
2015-06-25
Apoptosis signal-regulating kinase inhibitors
Grant 9,051,313 - Notte June 9, 2
2015-06-09
Fused Heterocyclic Compounds As Ion Channel Modulators
App 20150080370 - Kobayashi; Tetsuya ;   et al.
2015-03-19
Fused heterocyclic compounds as ion channel modulators
Grant 8,952,034 - Corkey , et al. February 10, 2
2015-02-10
Syk Inhibitors
App 20150038488 - Currie; Kevin S. ;   et al.
2015-02-05
Apoptosis signal-regulating kinase inhibitors
Grant 8,927,582 - Corkey , et al. January 6, 2
2015-01-06
Fused Heterocyclic Compounds As Ion Channel Modulators
App 20140303158 - Corkey; Britton ;   et al.
2014-10-09
Apoptosis Signal-regulating Kinase Inhibitor
App 20140228412 - Notte; Gregory
2014-08-14
Apoptosis Signal-regulating Kinase Inhibitor
App 20140228411 - Notte; Gregory
2014-08-14
Apoptosis Signal-regulating Kinase Inhibitors
App 20140179663 - Notte; Gregory
2014-06-26
Apoptosis signal-regulating kinase inhibitor
Grant 8,742,126 - Notte June 3, 2
2014-06-03
Fused heterocyclic compounds as ion channel modulators
Grant 8,703,759 - Kobayashi , et al. April 22, 2
2014-04-22
Apoptosis Signal-regulating Kinase Inhibitors
App 20140018370 - Corkey; Britton Kenneth ;   et al.
2014-01-16
Apoptosis signal-regulating kinase inhibitors
Grant 8,598,360 - Corkey , et al. December 3, 2
2013-12-03
Apoptosis signal-regulating kinase inhibitors
Grant 8,552,196 - Corkey , et al. October 8, 2
2013-10-08
Apoptosis Signal-regulating Kinase Inhibitors
App 20130203819 - Corkey; Britton ;   et al.
2013-08-08
Apoptosis Signal-regulating Kinase Inhibitor
App 20130197037 - Notte; Gregory
2013-08-01
Apoptosis signal-regulating kinase inhibitors
Grant 8,440,665 - Corkey , et al. May 14, 2
2013-05-14
Apoptosis signal-regulating kinase inhibitors
Grant 8,378,108 - Corkey , et al. February 19, 2
2013-02-19
Apoptosis Signal-regulating Kinase Inhibitors
App 20130035339 - Corkey; Britton ;   et al.
2013-02-07
Apoptosis Signal-regulating Kinase Inhibitors
App 20130012521 - Corkey; Britton ;   et al.
2013-01-10
Fused Heterocyclic Compounds As Ion Channel Modulators
App 20120289493 - Corkey; Britton Kenneth ;   et al.
2012-11-15
Fused Heterocyclic Compounds as Ion Channel Modulators
App 20120010192 - Kobayashi; Tetsuya ;   et al.
2012-01-12
Apoptosis Signal-regulating Kinase Inhibitors
App 20120004267 - Corkey; Britton ;   et al.
2012-01-05
Fused Heterocyclic Compounds As Ion Channel Modulators
App 20110021521 - Corkey; Britton ;   et al.
2011-01-27
Apoptosis Signal-regulating Kinase Inhibitors
App 20110009410 - Corkey; Britton ;   et al.
2011-01-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed